These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1174351

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.
    Bakowski MT.
    Cancer Treat Rev; 1976 Jun; 3(2):95-107. PubMed ID: 821609
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Lazan DW, Heston WD, Kadmon D, Fair WR.
    Cancer Res; 1982 Apr; 42(4):1390-4. PubMed ID: 7060012
    [Abstract] [Full Text] [Related]

  • 6. The effects of an antimetastatic agent, (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior.
    Atherton A, Busfield D, Hellman K.
    Cancer Res; 1975 Apr; 35(4):953-7. PubMed ID: 1116152
    [Abstract] [Full Text] [Related]

  • 7. Antimetastatic effects of razoxane in a rat osteosarcoma model.
    Wingen F, Spring H, Schmähl D.
    Clin Exp Metastasis; 1987 Apr; 5(1):9-16. PubMed ID: 3470164
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159).
    Lazo JS, Ingber DE, Sartorelli AC.
    Cancer Res; 1978 Aug; 38(8):2263-70. PubMed ID: 667822
    [No Abstract] [Full Text] [Related]

  • 9. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Salsbury AJ, Burrage K, Hellmann K.
    Cancer Res; 1974 Apr; 34(4):843-9. PubMed ID: 4814997
    [No Abstract] [Full Text] [Related]

  • 10. Influence of ICRF 159 and trition WR 1339 on metastases of a rat epithelioma.
    Pimm MV, Baldwin RW.
    Br J Cancer; 1975 Jan; 31(1):62-7. PubMed ID: 1156509
    [Abstract] [Full Text] [Related]

  • 11. Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma.
    James SE, Salsbury AJ.
    Cancer Res; 1974 Apr; 34(4):839-42. PubMed ID: 4814996
    [No Abstract] [Full Text] [Related]

  • 12. Combination of radiation and razoxane (ICRF 159) in vivo.
    Hellmann K, Grimshaw MB, Hutchinson GE.
    Int J Radiat Oncol Biol Phys; 1978 Apr; 4(1-2):109-13. PubMed ID: 632139
    [No Abstract] [Full Text] [Related]

  • 13. Effect of AT1727 on growth and metastasis of murine tumours.
    Li XT, Hutchinson GE, Pym BA, Finch M, Hellmann K.
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):283-7. PubMed ID: 6681774
    [Abstract] [Full Text] [Related]

  • 14. Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor.
    Heston WD, Kadmon D, Fair WR.
    Cancer Lett; 1981 Jul; 13(2):139-45. PubMed ID: 7306951
    [Abstract] [Full Text] [Related]

  • 15. ICRF-159: current status and clinical prospects.
    Bellet RE, Rozencweig M, Von Hoff DD, Penta JS, Wasserman TH, Muggia FM.
    Eur J Cancer (1965); 1977 Nov; 13(11):1293-8. PubMed ID: 590286
    [No Abstract] [Full Text] [Related]

  • 16. Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.
    Taylor RH, Gilbert JM, Evans MG, Lane HG, Cassell PG.
    Clin Exp Metastasis; 1984 Nov; 2(4):321-31. PubMed ID: 6399698
    [Abstract] [Full Text] [Related]

  • 17. ICRF-187 in clinical oncology.
    Poster DS, Penta JS, Bruno S, Macdonald JS.
    Cancer Clin Trials; 1981 Nov; 4(2):143-6. PubMed ID: 6788388
    [Abstract] [Full Text] [Related]

  • 18. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T, Sava G, Cuman R, Nisi C, Lassiani L.
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [Abstract] [Full Text] [Related]

  • 19. Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159.
    Pollard M, Burleson GR, Luckert PH.
    Prostate; 1981 Jun; 2(1):1-9. PubMed ID: 7279810
    [Abstract] [Full Text] [Related]

  • 20. Clinical trials with bis-dioxopiperazine propane (ICRF 159; NSC 129, 943) in acute leukaemias.
    Krepler P, Pawlowsky J.
    Osterr Z Onkol; 1975 Jun; 2(4):112-4. PubMed ID: 772517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.